Paper3583643
Spirogermanium--a novel antitumour agent expressing a lack of cross-resistance in vitro with a range of 'standard' antitumour drugs.
Hill BT and 1 other. Invest New Drugs, 1986. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. Spirogermanium--a novel antitumour agent expressing a lack of cross-resistance in vitro with a range of 'standard' antitumour drugs. Papers, record 3583643. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3583643
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Spirogermanium--a novel antitumour agent expressing a lack of cross-resistance in vitro with a range of 'standard' antitumour drugs.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Organometallic Compounds | Major topic |
| Spiro Compounds | Major topic |
| Animals | |
| Antineoplastic Combined Chemotherapy Protocols | |
| Cell Line | |
| Cell Survival | |
| Drug Resistance | |
| Humans |
Source PubMed
References22
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 7060033 | Rationale for the use of alternating non-cross-resistant chemotherapy. | Cancer Treat Rep | 1982 | https://conductscience.org/library/papers/7060033 | PubMed |
| 2 | 3909806 | A phase II study of spirogermanium in advanced human malignancy. | Am J Clin Oncol | 1985 | https://conductscience.org/library/papers/3909806 | PubMed |
| 3 | 5533992 | Cellular resistance to actinomycin D in Chinese hamster cells in vitro: cross-resistance, radioautographic, and cytogenetic studies. | Cancer Res | 1970 | https://conductscience.org/library/papers/5533992 | PubMed |
| 4 | 343804 | An in vitro colony assay for human tumours grown in immune-suppressed mice and treated in vivo with cytotoxic agents. | Br J Cancer | 1978 | https://conductscience.org/library/papers/343804 | PubMed |
| 5 | 4357757 | A human cell line from a pleural effusion derived from a breast carcinoma. | J Natl Cancer Inst | 1973 | https://conductscience.org/library/papers/4357757 | PubMed |
| 6 | 6947891 | Concepts for controlling drug-resistant tumor cells. | Eur J Cancer (1965) | 1980 | https://conductscience.org/library/papers/6947891 | PubMed |
| 7 | 6354434 | Multidrug-resistance phenotype in Chinese hamster ovary cells. | Cancer Treat Rep | 1983 | https://conductscience.org/library/papers/6354434 | PubMed |
| 8 | 7200828 | Cytotoxic effects and biological activity of 2-aza-8-germanspiro[4,5]-decane-2-propanamine-8,8-diethyl-N,N-dimethyl dichloride (NSC 192965; spirogermanium) in vitro. | Cancer Res | 1982 | https://conductscience.org/library/papers/7200828 | PubMed |
| 9 | 6678870 | Spirogermanium: a new investigational drug of novel structure and lack of bone marrow toxicity. | Invest New Drugs | 1983 | https://conductscience.org/library/papers/6678870 | PubMed |
| 10 | 709555 | In vivo characteristics of resistance and cross-resistance of an adriamycin-resistant subline of P388 leukemia. | Cancer Treat Rep | 1978 | https://conductscience.org/library/papers/709555 | PubMed |
| 11 | 4855907 | Reduced permeability in CHO cells as a mechanism of resistance to colchicine. | J Cell Physiol | 1974 | https://conductscience.org/library/papers/4855907 | PubMed |
| 12 | 6137059 | Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines. | Science | 1983 | https://conductscience.org/library/papers/6137059 | PubMed |
| 13 | 986302 | The value of adriamycin in overcoming resistance to methotrexate in tissue culture. | Eur J Cancer (1965) | 1976 | https://conductscience.org/library/papers/986302 | PubMed |
| 14 | 7105380 | Establishment of Vincristine-resistant and vindesine-resistant lines of murine lymphoblasts in vitro and characterisation of their patterns of cross-resistance and drug sensitivities. | Cancer Chemother Pharmacol | 1982 | https://conductscience.org/library/papers/7105380 | PubMed |
| 15 | 281559 | Resistance and cross-resistance of cultured leukemia P388 cells to vincristine, adriamycin, adriamycin analogs, and actinomycin D. | J Natl Cancer Inst | 1978 | https://conductscience.org/library/papers/281559 | PubMed |
| 16 | 6576190 | Preclinical screening for drugs effective against 5-fluorouracil-resistant cells with a murine L5178Y cell line in vitro. | J Natl Cancer Inst | 1983 | https://conductscience.org/library/papers/6576190 | PubMed |
| 17 | 6354435 | Vinca alkaloid-resistant phenotype in cultured human leukemic lymphoblasts. | Cancer Treat Rep | 1983 | https://conductscience.org/library/papers/6354435 | PubMed |
| 18 | 2857774 | Detection of P-glycoprotein in ovarian cancer: a molecular marker associated with multidrug resistance. | J Clin Oncol | 1985 | https://conductscience.org/library/papers/2857774 | PubMed |
| 19 | 57118 | Pleiotropic phenotype of colchicine-resistant CHO cells: cross-resistance and collateral sensitivity. | J Cell Physiol | 1976 | https://conductscience.org/library/papers/57118 | PubMed |
| 20 | 6540761 | Identification of synergistic combinations of spirogermanium with 5-fluorouracil or cisplatin using a range of human tumour cell lines in vitro. | Invest New Drugs | 1984 | https://conductscience.org/library/papers/6540761 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37687127 | A Theoretical Investigation of Novel Sila- and Germa-Spirocyclic Imines and Their Relevance for Electron-Transporting Materials and Drug Discovery. | Molecules | 2023 | https://conductscience.org/library/papers/37687127 | PubMed |
| 2924371 | Comparative effectiveness of mitoxantrone and doxorubicin in overcoming experimentally induced drug resistance in murine and human tumour cell lines in vitro. | Cancer Chemother Pharmacol | 1989 | https://conductscience.org/library/papers/2924371 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3583643
GET https://conductscience.org/api/papers/v1/3583643/references?page=2